Oversold, Lots of Cash, Great Partners, Falling Wedge

10 בנוב׳ 2014

This stock is ASKING for a pop on the chart. Falling wedge, lots of cash, great partners in Roche and Genentech, FDA approved drug, actual REVs and a solid balance sheet... long and strong at this price... $1.33